Immune repertoire sequencing reveals an abnormal adaptive immune system in COVID‐19 survivors

Секвенирование иммунного репертуара выявляет аномалии адаптивной иммунной системы у лиц, перенесших COVID-19
Song Li, Mingming Zhao, Erik De Clercq, Qianjin Lu, Guangdi Li, Qianqian Zhang, Keyu Li, Jia Chen, Xianglong Kong, Ming Yang, Haijing Wu, Zijun Wang, Pan Zhang, Bo Li, Jiyang Liu, Wenjing Pan, Zhiguo Zhou, Tingting Yue, Ting Cai, Ping Liu
2022-11-24

SARS-CoV-2 neutralizing antibodiesT-cell receptor/B-cell receptor clonesadaptive immune systemimmune repertoire sequencingsomatic hypermutation
Abstract Accumulating evidence suggests that severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) impairs the adaptive immune system during acute infection. Still, it remains largely unclear whether the frequency and functions of T and B cells return to normal after the recovery of Coronavirus Disease 2019 (COVID‐19). Here, we analyzed immune repertoires and SARS‐CoV‐2‐specific neutralization antibodies in a prospective cohort of 40 COVID‐19 survivors with a 6‐month follow‐up after hospital discharge. Immune repertoire sequencing revealed abnormal T‐ and B‐cell expression and function with large T cell receptor/B cell receptor clones, decreased diversity, abnormal class‐switch recombination, and somatic hypermutation. A decreased number of B cells but an increased proportion of CD19 + CD138 + B cells were found in COVID‐19 survivors. The proportion of CD4 + T cells, especially circulating follicular helper T (cTfh) cells, was increased, whereas the frequency of CD3 + CD4 − T cells was decreased. SARS‐CoV‐2‐specific neutralization IgG and IgM antibodies were identified in all survivors, especially those recorded with severe COVID‐19 who showed a higher inhibition rate of neutralization antibodies. All severe cases complained of more than one COVID‐19 sequelae after 6 months of recovery. Overall, our findings indicate that SARS‐CoV‐2‐specific antibodies remain detectable even after 6 months of recovery. Because of their abnormal adaptive immune system with a low number of CD3 + CD4 − T cells and high susceptibility to infections, COVID‐19 patients might need more time and medical care to fully recover from immune abnormalities and tissue damage.
1
A prospective six-month follow-up of 40 COVID-19 survivors revealed persistent abnormalities in adaptive immune repertoires after hospital discharge.
2
All participants with severe COVID-19 reported multiple sequelae after six months, suggesting prolonged immune abnormalities and delayed recovery requiring continued medical care.
3
SARS-CoV-2-specific neutralizing IgG and IgM antibodies remained detectable in every survivor six months after recovery, with higher inhibition rates among severe cases.
4
Survivors had fewer B cells but a higher proportion of CD19+CD138+ B cells, increased CD4+ and circulating follicular helper T cells, and fewer CD3+CD4− T cells.
5
T- and B-cell receptor repertoires showed expanded clones, reduced diversity, abnormal class-switch recombination, and altered somatic hypermutation.

The adaptive immune system of COVID-19 survivors during the 6 months after hospital discharge

Post-recovery abnormalities in T- and B-cell immune repertoires, cell composition and function, including persistent SARS-CoV-2-specific antibody responses

Publication Details
Publication Date
2022-11-24
Journal
Publisher
ISSN
Cited by
20
Access Type
Author Information
Authors
Song Li
Mingming Zhao
Erik De Clercq
Qianjin Lu
Guangdi Li
Qianqian Zhang
Keyu Li
Jia Chen
Xianglong Kong
Ming Yang
Haijing Wu
Zijun Wang
Pan Zhang
Bo Li
Jiyang Liu
Wenjing Pan
Zhiguo Zhou
Tingting Yue
Ting Cai
Ping Liu
Explore further
Open the scid.ai AI chat with a ready-made request: it will find papers on a similar topic and help build a literature review.
Find similar papers in the chat →
Make a presentation
100%